Citrin缺乏所致新生儿肝内胆汁淤积症预后分析

肝脏 ›› 2020, Vol. 25 ›› Issue (9): 961-964.

Citrin缺乏所致新生儿肝内胆汁淤积症预后分析

李静, 熊励晶, 杜丽娜, 蒋茂林, 杨静, 谢晓丽

610031 成都电子科技大学医学院附属医院·成都市妇女儿童中心医院儿童消化科

出版日期:2020-09-30 发布日期:2020-10-22
通讯作者: 谢晓丽,Email:xxlilye@qq.com
基金资助:
成都市卫计委项目(2017071)

Prognostic analysis of neonatal intrahepatic cholestasis caused by citrin deficiency

LI Jing, XIONG Li-jing, DU Li-na, JIANG Mao-lin, YANG Jing, XIE Xiao-li

Department of Pediatric Gastroenterology, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Sichuan 610031, China

Online:2020-09-30 Published:2020-10-22
Contact: XIE Xiao-li,Email:xxlilye@qq.com

摘要/Abstract

摘要： 目的探讨Citrin缺乏所致新生儿肝内胆汁淤积症(NICCD)患儿临床和实验室检查特征、突变基因及预后。方法以2017年1月至2019年12月成都市妇女儿童中心医院经基因确诊为Citrin缺乏所致新生儿肝内胆汁淤积症患儿6例为研究对象。收集其临床及实验室检测数据,并进行随访。结果 6例患儿平均出生体质量为2.95 kg,均于婴儿期起病。4例以皮肤黄染退而复现就诊,1例以生长迟缓就诊,1例以腹胀就诊。实验室检查结果提示6例患儿AST、γ-谷氨酰转肽酶、碱性磷酸酶、总胆红素、直接胆红素、总胆汁酸均升高,3例患儿ALT升高,2例伴血乳酸升高以及3例甲胎蛋白升高,1例白蛋白降低、2例活化部分凝血活酶时间延长。基因分析提示SLC25A13基因突变,包括:c.852-855del、c.615+5G>A、c.1177+1G>A、IVS16ins3kb、c.1362C>G、1210G>T c.1660-c.1661insGAGATTACAGGTGGCTGCCCGGG。就诊后予以无乳糖、强化中链甘油三酯配方奶喂养,其中5例平均治疗24 d症状明显缓解,1岁以内肝功能完全恢复正常,病例6就诊时已出现肝硬化、腹水、肝功能衰竭,伴发感染,最终放弃治疗。平均随访年龄1岁9月,均有喜高蛋白高脂饮食偏好。结论胆汁淤积性肝病患儿原因分析时应考虑到NICCD,早期就诊,早期行基因分析有助于早期确诊,确诊后给予饮食干预,治疗效果好,预后可,但仍需长期随访。

关键词: Citrin缺乏, 新生儿肝内胆汁淤积症

Abstract: Objective To investigate the clinical and laboratory features, gene mutations and prognosis of neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD). Methods Six NICCD patients diagnosed by gene detection from January 2017 to December 2019 in our department were enrolled. Clinical data of these patients were collected and analyzed. Results The average birth weight of the 6 patients was 2.95 kg, and all of them experienced disease onset in infant period. The chief complaints were repeated jaundice (4/6), growth retardation (1/6) and abdominal distension (1/6). Laboratory data showed that all the 6 patients had increased aspartate aminotransferase, γ-glutamyl transferase, alkaline phosphatase, total bilirubin, direct bilirubin and total bile acid. Most had increased alanine aminotransferase (3/6), increased lactic acid (2/2), increased alphafetoprotein (3/3), decreased albumin (1/6) and prolonged activated partial thromboplastin time (2/4). Mutations were found in SLC25A13 gene, which included c.852-855del, c.615+5G>A, c.1177+1G>A, IVS16ins3kb, c.1362C>G, 1210G>T, and c.1660-c.1661insGAGATTACAGGTGGCTGCCCGGG. After feeding with lactose-free and medium-chain triglyceride-rich formula, liver function improved 24 days later and normalized completely within 1 year in 5 of the infants. Another case had cirrhosis, ascites and liver failure, accompanied by infection at first visit and finally gave up treatment. The average follow-up age was 1 year and 9 months. All of them had the preference for a high protein and high fat diet. Conclusion NICCD should be taken into account in the etiology of infant cholestasis. Early visit and early genetic testing are helpful in early diagnosis. Most Children with NICCD have good prognosis after diet intervention, and long-term follow-up is required.

Key words: Citrin deficiency, Neonatal intrahepatic cholestasis

李静, 熊励晶, 杜丽娜, 蒋茂林, 杨静, 谢晓丽. Citrin缺乏所致新生儿肝内胆汁淤积症预后分析[J]. 肝脏, 2020, 25(9): 961-964.

LI Jing, XIONG Li-jing, DU Li-na, JIANG Mao-lin, YANG Jing, XIE Xiao-li. Prognostic analysis of neonatal intrahepatic cholestasis caused by citrin deficiency[J]. Chinese Hepatolgy, 2020, 25(9): 961-964.

参考文献

[1] Kobayashi K, Sinasac DS, Iijima M, et al . The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein. Nat Genet, 1999, 22: 159-163.
[2] Lu YB, Kobayashi K, Ushikai M, et al. Frequency and distribution in East Asia of 12 mutations identified in the SLC25A13 gene of Japanese patients with citrin deficiency. J. Hum. Genet, 2005, 50: 338-346.
[3] 张婧, 王晓红, 叶颖子, 等. 白蛋白在诊断Citrin缺陷导致的新生儿肝内胆汁淤积症的价值. 中华肝脏病杂志, 2016, 24:755-760.
[4] 刘晶莹,苗静琨, 花媛媛, 等. Citrin蛋白缺乏致新生儿肝内胆汁淤积症:更新的认识. 临床儿科杂志, 2016:949-953,955.
[5] 董永绥. 婴儿胆汁淤积性肝病研究进展及展望. 中国实用儿科杂志, 2013:6-10.
[6] Lin WX, Zeng HS, Zhang ZH, et al. Molecular diagnosis of pediatric patients with citrin deficiency in China: SLC25A13 mutation spectrum and the geographic distribution. Scientific Reports, 2016, 6:29732.
[7] Chong SC, Lo P, Chow CW, et al. Molecular and clinical characterization of citrin deficiency in a cohort of Chinese patients in Hong Kong. Mol Genet Metab Rep, 2018, 17: 3-8.
[8] Saheki T, Kobayashi K. Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD).J. Hum. Genet, 2002, 47: 333-341.
[9] Oh SH, Lee BH, Kim GH, et al. Biochemical and molecular characteristics of citrin deficiency in Korean children. J. Hum. Genet, 2017, 62: 305-307.
[10] Abuduxikuer K, Chen R, Wang ZL, et al. Risk factors associated with mortality in neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) and clinical implications. BMC Pediatr, 2019, 19: 18.
[11] Chang KW, Chen HL, Chien YH, et al. SLC25A13 gene mutations in Taiwanese patients with non-viral hepatocellular carcinoma. Mol. Genet. Metab, 2011, 103: 293-296.
[12] He JY, Zhang JL, Li XS, et al. A case report: can citrin deficiency lead to hepatocellular carcinoma in children. Front Pediatr, 2019, 7: 371.
[13] Wang LM, Wang LF, Zhu SS, et al. A 6-year-old child with citrin deficiency and advanced hepatocellular carcinoma. Pediatrics, 2019, 143.